The role of civil society in protecting public health over commercial interests: lessons from Thailand

Lancet. 2004 Feb 14;363(9408):560-3. doi: 10.1016/S0140-6736(04)15545-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / epidemiology
  • Anti-HIV Agents / economics
  • Anti-HIV Agents / supply & distribution*
  • Anti-HIV Agents / therapeutic use
  • Commerce / legislation & jurisprudence*
  • Didanosine / economics
  • Didanosine / supply & distribution
  • Didanosine / therapeutic use
  • Drug Costs / legislation & jurisprudence
  • Drug Industry / legislation & jurisprudence*
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • Health Services Accessibility / legislation & jurisprudence*
  • Humans
  • Intellectual Property
  • Patents as Topic / legislation & jurisprudence*
  • Patient Rights / legislation & jurisprudence
  • Public Health Administration*
  • Thailand / epidemiology

Substances

  • Anti-HIV Agents
  • Didanosine